BCG fails 30 to 40% of patients with high-risk non-muscle-invasive bladder cancer.1

Of those who then try to keep their bladder, 58% lose it to cystectomy within five years, and by that point 42% have locally advanced or node-positive disease.2

We intend to make cystectomy the exception in this population rather than the destination.

Please note: Obrix Bio operates in a stealth capacity.

Someone on the team reads every message. Details are held only so that we can answer. Privacy statement.